An antibody cocktail targeting two different CD73 epitopes enhances enzyme inhibition and tumor control (Nature Communications, 2024)

(untitled) - Xu, J; Chen, S; He, Y; Zhu, X; Wang, Y; Ye, Z; Zhou, JC; Wu, X; Zhang, L; Ren, X; Jia, H; Yu, H; et al.